Actively supporting and cultivating a culture of research, especially among our young clinicians, enables us to continuously find better treatments for our patients. Dr. Sim Hui Wen recaps on the European Society of Cardiology (ESC) Congress 2016, where NUHCS not only gained knowledge from worldwide clinicians but also achieved recognition for our research work.
The ESC Congress, first held in 1988, is the world’s largest and most influential cardiovascular meeting. It is a platform for cardiologists to share the latest advances in heart disease treatments.
The latest ESC Congress was held in Rome, Italy from 27-31 August 2016 and was attended by some 32,000 cardiovascular professionals from around the world. His Holiness Pope Francis also graced the congress to address his high regard for scientific research.
Boosting Cardiology Research
The highlights of the congress include ‘The Heart Team’ which emphasised on the importance of teamwork across all specialties; the ESC Clinical Practice Guidelines sessions; and the presentation of 30 novel clinical trials. Prof. Tan Huay Cheem, Director, NUHCS also chaired a session on transcatheter mitral intervention1
, alongside Prof. Jeroen Bax, President-elect of ESC. Together, they provided valuable insights into the role of mitral clip in current clinical practice and novel transcatheter mitral valve surgery techniques.
NUHCS Gains Recognition
The congress received a total of 11,000 abstracts from 106 countries. Dr. Yeo Tee Joo, Consultant, NUHCS won the best moderated poster presentation award for his work on young athletes and bicuspid aortic valve disease, in collaboration with St George’s, University of London. Several of our clinicians also showcased their research works across different areas of cardiology.
By Dr. Sim Hui Wen
A minimally invasive technique that treats mitral regurgitation, a condition in which the heart’s mitral valve doesn't close tightly, causing blood to flow backward in the heart.